Newscast – Page 64 – media

Hospira Inc. Recalls Opioid Antidote Naloxone

According to the FDA, if the antidote drugs are used on a patient, they could suffer from “allergic reactions, local irritation” and a wide number of cardiovascular issues, including restriction of blood supply to tissues. The FDA stated that there has not yet been any reports of patient harm from Naloxone.
- Source: Ddu
- 610
- June 7, 2018
Company Insights FDA opioid
Apple to launch new Health Record API for developers

This week Apple announced that researchers and app developers can now have access to a Health Record API (Application Programming Interface) to develop applications, with the permission to use the patient’s data to provide them with easy access to health records.
- Source: drugdu
- 709
- June 7, 2018
Company Insight digital health mHealth
Smartphone Video Based App for TB

A research team from John Hopkins University School of Medicine created a cost-effective and patient-centric smartphone video-based app, which would substitute the daily in-person visits by a healthcare worker required for TB therapy, known as DOT (Directly Observed Therapy).
- Source: Ddu
- 792
- June 7, 2018
mHealth Researches tuberculosis
Blood Test to Predict Drug Activity Against Breast Cancer

At present, breast cancer patients need to wait for nearly two to three months to find out via a scan whether palbociclib is working. This new test could detect the circulating tumor DNA which enters the bloodstream. By measuring and comparing PIK3CA levels in a blood test before and 15 post palbociclib therapy, one could predict the effectiveness of the drug.
- Source: Ddu
- 886
- June 7, 2018
blood test breast cancer Researches
Therapy Against Progeria

After conducting a clinical trial study at Boston Children’s Hospital, scientists from Brown University recommended that a lonafarnib therapy could increase the survival rate of progeria patients. But the mode of action of lonafarnib is still uncertain.
- Source: Ddu
- 533
- June 7, 2018
progeria rare diseases Researches
Lynparza and Zytiga Combo Effective Against Prostate Cancer

Along with new drug partner Merck, the British drugmaker displayed results showing that adding Lynparza to Johnson & Johnson prostate cancer fighter Zytiga was a more potent disease-fighter than Zytiga alone. As compared to a time-frame of 8.2 months for solo Zytiga, the combo effectively prevented disease progression for 13.8 months.
- Source: Ddu
- 764
- June 6, 2018
AstraZeneca Clinical Trials Company Insight prostate cancer
How Much is Too Much Caffeine?

Kathleen Miller, an energy-drink specialist from the University at Buffalo Research Institute on Addictions said, "Caffeine can be a great thing, at low doses; with the consumption of five 5-hour Energy drinks, however, you move past alert and awake, into the territory of jittery, anxious and heart palpitations." Caffeine doses higher than 5000 mg can lead to seizures, hallucinations and strokes.
- Source: Ddu
- 568
- June 6, 2018
caffiene health tips Researches
Avoid Green Tea with an Iron Rich Diet

The major component named epigallocatechin-3-gallate (EGCG) in green tea inhibits myeloperoxidase enzymes released by white blood cells during inflammatory bowel disease outbursts. But when green tea was consumed with iron, EGCG bound with the iron and the ability to inhibit myeloperoxidase was lost.
- Source: Ddu
- 478
- June 6, 2018
diet health tips Researches
Discovery of Natural Blackcurrant Hair Dye

Hair dye poisoning is one of the major causes of self-injury. Chemical hair dye, especially paraphenylene-diamine can lead to edemas, rhabdomyolysis, acute metabolic acidosis and renal failure. Scientists from the University of Leeds have extracted natural dyes from blackcurrant waste, generated throughout Ribena blackcurrant production. This natural black dye with zero side effects could be used in fresh new hair dyeing technologies.
- Source: Ddu
- 463
- June 6, 2018
hair Researches toxicity
Invention of Antimicrobial Medical Gloves

Professor James, the lead researcher said, “These gloves will be a game-changer for the healthcare industry, both public and private. I am delighted that my lifetime’s research into bacteria and antibiotic resistance has directly informed the science behind a practical tool that will have a major impact on medical care in the future.”
- Source: Ddu
- 514
- June 6, 2018
medical device products Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.